UCB SA has ended the first nine months of 2012 with revenue of €2,565 million, up by 5% from a year earlier and profit in line with expectations. The Belgian company has confirmed its 2012 forecast for sales in excess of €3.2 billion. ---Subscribe to MedNous to access this article--- Company News
